Clinical trialNCT02555761CompletedObservational

Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

SponsorAllerganEnrollment3,423Conjunctivitis, Allergic

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This post-marketing surveillance study will assess the safety and efficacy of Lastacaft® Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic Conjunctivitis as prescribed as standard of care in clinical practice in Korea.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Yan Bai
Allergan
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea

Barun Sungmo Eye Clinic
Busan, South Korea
Daeyeon St.Mary'S Eye Center
Busan, South Korea
Dong-A University Hospital
Busan, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Inje University Haeundae Paik Hospital
Busan, South Korea
Pusan National University Hospital
Busan, South Korea
Pusan National University Yangsan Hospital
Busan, South Korea
Saint Mary Bright Eye Clinic
Busan, South Korea
Seo-Myeon St.Mary'S Hospital
Busan, South Korea
Seomyeon St. Eye Clinic
Busan, South Korea
Soojung Eye Hospital
Busan, South Korea
Chamjoeun Ophthalmic Clinic
Busan, South Korea
Soonchunhyang University Cheonan Hospital
Chungcheongnam-do, South Korea
Cheil Eye Hospital
Daegu, South Korea
Daegu Nune Eye Hospital
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Kyoungpook National University Hospital
Daegu, South Korea
Chonnam National University Hospital
Daejeon, South Korea
Clean Eye Clinic
Daejeon, South Korea
Eye Love Eye Center
Daejeon, South Korea
Jungbuwoorieye Clinic
Daejeon, South Korea
Konyang University Hospital
Daejeon, South Korea
Saebom Eye Clinic
Daejeon, South Korea
Chonnam National University Hospital
Daejoen, South Korea
Konyang University Hospital
Daejoen, South Korea
St. Mary'S Eye Center
Geyonggi-do, South Korea
Eins Eye Clinic
Geyonsangnam-do, South Korea
Bora Eye Clinic
Gwangju, South Korea
Bora Eye Clinic
Gwangju, South Korea
Gwang Ju Eye Clinic
Gwangju, South Korea
Happ Eye 21
Gwangju, South Korea
Ansan Yonsei Eye Center
Gyeonggi-do, South Korea
Anyang Seoul Eye Clinic
Gyeonggi-do, South Korea
Bright Eye
Gyeonggi-do, South Korea
Eagle Eye Center
Gyeonggi-do, South Korea
Munsan Jeil Eye Clinic
Gyeonggi-do, South Korea
Myongji Hospital
Gyeonggi-do, South Korea
Noon-Sarang Eye Hospital
Gyeonggi-do, South Korea
Seoul Shinsegae Eye Center
Gyeonggi-do, South Korea
Yonsei Dream Eye Clinic
Gyeonggi-do, South Korea

41 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Alcaftadine Ophthalmic Solution 0.25%

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Oct 2015
Primary completion: 19 Mar 2018
Completion: 19 Mar 2018
Last update posted: 5 Jul 2019
Registered enrollment: 3,423
Registry id: NCT02555761

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.